Meeting
2015 Gastrointestinal Cancers Symposium
Prognostic value of RAS, BRAF, and PIK3CA mutations in early-stage colorectal cancer.
Authors
Jennifer Elizabeth Byer
University of South Florida, Tampa, FL
Jennifer Elizabeth Byer , Nishi Kothari , TzuHua Juan , Jamie K. Teer , Michael J. Schell , David Shibata , Richard D. Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 594)
DOI
10.1200/jco.2015.33.3_suppl.594
Abstract #
594
Poster Bd #
B38
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
The nationwide genomic screening project for gastrointestinal cancer in Japan (GI-SCREEN): Simultaneous identification of KRAS, NRAS, BRAF, and PIK3CA mutation in advanced colorectal cancer (aCRC) (GI-SCREEN 2013-01).
First Author: Kohei Shitara
Poster
2012 ASCO Annual Meeting
BRAF, PIK3CA, and PTEN status and benefit from cetuximab (CET) in the treatment of advanced colorectal cancer (CRC): Results from NCIC CTG/AGITG CO.17.
First Author: Derek J. Jonker
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Clinical characteristics and survival analysis in patients with isolated pulmonary metastases from colorectal cancer (CRC).
First Author: Javier Soto Alsar
First Author: Yoo Jin Joung